Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials

BACKGROUND: While open‐label randomized controlled trials (RCT) are common in oncology, some concerns have been expressed with regard to Patient‐Reported Outcomes (PRO)‐based claims stemming from these studies. We aimed to investigate the impact of open‐label design in the context of prostate cancer...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Med
Hoofdauteurs: Mouillet, Guillaume, Efficace, Fabio, Thiery‐Vuillemin, Antoine, Charton, Emilie, Van Hemelrijck, Mieke, Sparano, Francesco, Anota, Amélie
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Clinical Cancer Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7571808/
https://ncbi.nlm.nih.gov/pubmed/32846465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3335
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items